Acute Viral Rhinosinusitis Treatment Market to Cross US$ 3.16 Bn by 2031, Finds TMR Study

- Increasing microbial resistance for antibiotics stimulates R&D for routine conjugated pneumococcal vaccination and to examine recommended high dose of amoxicillin and clavulanate for patients of pneumococcal resistance

- Efficacy of nasal saline irrigation drives companies in the acute viral rhinosinusitis treatment market to increase their output capacities of topical intranasal therapies to reduce congestion in patients

ALBANY, N.Y., Jan. 13, 2022 /PRNewswire/ -- The acute viral rhinosinusitis treatment market is estimated to expand at a CAGR of 5.3% during the forecast period, from 2021 to 2031. The rising occurrence of rhinosinusitis and acute rhinosinusitis are primary factors fueling the growth of acute viral rhinosinusitis market. According to published data, rhinosinusitis accounted for 12 million to 17 million physician visits, and 12% of antibiotics administered to senior patients in the U.S.

North America led the acute viral rhinosinusitis treatment market in 2020 and is anticipated to continue to lead during the forecast period. The Asia Pacific acute viral rhinosinusitis treatment market is anticipated to gain from increasing investments in R&D for pharmaceutical drugs. Increase in awareness about acute viral rhinosinusitis and focus on discovering novel treatment drugs are likely to fuel the growth of Europe acute viral rhinosinusitis treatment market.

Request Brochure of Acute Viral Rhinosinusitis Treatment Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82764 

Acute Viral Rhinosinusitis Treatment Market – Key Findings of Report

• Risk of exposure of patients of severe chronic rhinosinusitis with nasal polyps to COVID-19 drives companies in the acute viral rhinosinusitis market to expand output capacity of dupilumab to improve patient outcomes. Dupilumab helps to improve sinonasal function, which is initially essential to fight against coronavirus.
• Companies in the acute viral rhinosinusitis treatment market are expanding their output capacities in topical intranasal therapies for nasal saline irrigation to reduce congestion
• Topical nasal corticosteroids are expected to account for the second-leading revenue among all treatment types in the acute viral rhinosinusitis treatment market. Clinically, topical corticosteroid nasal sprays help to reduce mucosal inflammation and thus, reduce blockage of the sinus drainage pathways.
• Topical antihistamine lowers inflammation and irritation of the mucosa, and at the same time, reduces edema in the nasal passage and opens up the sinus ostia
• New product launches and increase in product approvals favor the growth of the acute viral rhinosinusitis treatment market. For instance, in December 2020, AstraZeneca announced marketing authorization from the Drugs Controller General of India for using Fasenra only for patients of severe asthma or chronic rhinosinusitis
• Oral route of administration segment led the acute viral rhinosinusitis market in 2020, owing to its convenient, cost-effective, and commonly used route of administration of medication

Request for Analysis of COVID-19 Impact on Acute Viral Rhinosinusitis Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82764 

• Inadequacy of antibiotics to prevent clinical complications of bacterial acute rhinosinusitis has led to the consideration for individual examination before prescribing antibiotics
• Efforts for increasing the availability of clavulanate and amoxicillin are underway as a means of suitable initial therapy for acute viral rhinosinusitis in individuals who do not have risk factors for resistance for these medications
• Stakeholders and healthcare providers need to play a role to create awareness that acute viral rhinosinusitis is a self-resolving and mild disease to reduce the burden of large number of medical visits

Acute Viral Rhinosinusitis Treatment Market – Growth Drivers

• Increasing number of patients of rhinosinusitis drives the acute viral rhinosinusitis treatment market. According to CDC, in 2018, 28.9 million individuals in the U.S. were diagnosed with rhinosinusitis
• Expanding awareness about sinusitis treatment and new product launches to propel the acute viral rhinosinusitis treatment market

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=82764

Acute Viral Rhinosinusitis Treatment Market – Key Players

Some of the key players operating in the acute viral rhinosinusitis market are;

• Sun Pharmaceutical Industries Inc.
• Janssen Pharmaceuticals Inc.
• Dr. Reddy's Laboratories Inc.
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• AstraZeneca plc
• GlaxoSmithKline plc
• Hikma Pharmaceuticals plc
• Pfizer Inc.
• Fresenius Kabi USA LLC
• Novartis AG
• Sanofi
• Eli Lilly and Company
• Merck & Co. Inc.
• Amneal Pharmaceuticals LLC
• Mylan N.V.
• Wockhardt

Buy Acute Viral Rhinosinusitis Treatment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=82764&ltype=S 

The Acute Viral Rhinosinusitis Treatment Market is segmented as follows;

Acute Viral Rhinosinusitis Treatment Market, by Treatment

• Saline Nasal Spray
• Nasal Corticosteroids
• Fluticasone
• Budesonide
• Mometasone
• Others
• Decongestants
• Topical Decongestants
• Systemic Decongestants
• NSAIDs
• Acetaminophen
• Ibuprofen
• Aspirin
• Others
• Others

Acute Viral Rhinosinusitis Treatment Market, by Route of Administration

• Topical
• Nasal
• Oral
• Injectable

Global Acute Viral Rhinosinusitis Treatment Market, by Distribution Channel

• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies

Acute Viral Rhinosinusitis Treatment Market, by Infection Type

• Rhinovirus (Picornavirus)
• Non-Rhinovirus
• Influenza
• Enterovirus
• Adenovirus
• Others

Acute Viral Rhinosinusitis Treatment Market, by Region

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Myasthenia Gravis Market: Myasthenia gravis market for the historical period 2018–2019 and forecast period 2020–2030, high prevalence of autoimmune diseases and strong focus on introducing new therapies is augmenting the growth of global myasthenia gravis market. Moreover, improving healthcare infrastructure is likely boost the growth of global myasthenia gravis market during the forecast period.

Alpha Mannosidosis Market: Alpha mannosidosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027'. According to the report, the global alpha mannosidosis market was valued at US$ 7.6 Mn in 2018 and is projected to expand at a CAGR of 9.9% from 2019 to 2027. North America accounted for major share of the global alpha mannosidosis market in 2018, owing to high prevalence rates.

Microbiology Culture Market: Global microbiology culture market was valued at US$ 5.7 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027. The microbiology culture market has grown significantly in the last few decades in terms of demand in various end-use industries. Academia, clinical research organizations, and commercial end-use industries such as pharmaceutical, cosmetics, and food & beverages are providing impetus to the global microbiology culture market.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 
Follow Us: Twitter | LinkedIn 
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/acute-viral-rhinosinusitis-treatment-market.htm 

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg